DCP1A and colorectal carcinoma: In CRC, DCP1A expression is elevated, which is associated with advanced TNM stages, lymph node metastasis and poor prognosis, and overexpression of DCP1A enhances P-body formation (Wu et al., 2018a; Wu et al., 2018b).